Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Haemotronic is an Italian medical device and components manufacturer focused on disposable products for the healthcare and pharmaceutical industries. The company develops and manufactures medical components, tubing and lay-flat materials, IV and pharmaceutical bags, and finished or semi-finished assemblies used in transfusion, infusion, and related care settings. Its manufacturing capabilities include injection molding, extrusion, thermoforming, welding, assembly, and sterilization processes, supporting OEM and customized production. Founded in 1979 in Mirandola, Italy, Haemotronic was acquired by GVS in May 2022 and continues to operate as part of the GVS medtech portfolio. The business appears commercially focused rather than drug-development focused, with no evident therapeutic pipeline or clinical-stage assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Haemotronic.